Name (Synonyms) | Correlation | |
---|---|---|
drug836 | Elisa-test for IgM and IgG to SARS-CoV-2 Wiki | 1.00 |
drug1534 | Muse headband with Myndlift app Wiki | 1.00 |
drug1173 | IgM and IgG diagnostic kits to SARS-CoV-2 Wiki | 1.00 |
There is one clinical trial.
This study will evaluate the effect of a manualized treatment (Goal Management Training, or GMT) on the cognitive impairments associated with PTSD (Post-Traumatic Stress Disorder) in certain populations. Participants will be randomized to either GMT group treatment (with or without use of a mindfulness meditation aid), or a wait-list condition.
Description: A computer-based go/no-go task that requires participants to withhold behavioral response to a single, infrequent target presented amidst a background of frequent non-targets. This task assesses inattentiveness, impulsivity, sustained attention, and vigilance.
Measure: Change in Sustained Attention to Response Task (SART) scores from baseline to post-treatment assessment Time: 9 weeksDescription: A computer-based go/no-go task that requires participants to withhold behavioral response to a single, infrequent target presented amidst a background of frequent non-targets. This task assesses inattentiveness, impulsivity, sustained attention, and vigilance.
Measure: Change in Sustained Attention to Response Task (SART) scores from post-treatment to 3-month follow-up assessment Time: 12 weeksDescription: Assesses the participant's ability to act with forethought, and sequence behaviour in an orderly fashion to reach specific goals (i.e., executive functioning). Similar to the Tower of London test.
Measure: Change in score on Spatial Planning task (part of Cambridge Brain Science's online battery) from baseline to post-treatment assessment. Time: 9 weeksDescription: Assesses the participant's ability to act with forethought, and sequence behaviour in an orderly fashion to reach specific goals (i.e., executive functioning). Similar to the Tower of London test.
Measure: Change in score on Spatial Planning task (part of Cambridge Brain Science's online battery) from post-treatment to 3-month follow-up assessment. Time: 12 weeksDescription: A 36-item self-report measure that assesses difficulties with emotion regulation across six domains. A total score is derived by summing all the items - ranging from 36 to 180. Higher scores indicate greater dysfunction in emotion regulation.
Measure: Change in Difficulties in Emotion Regulation Scale (DERS) score from baseline to post-treatment assessment Time: 9 weeksDescription: A 36-item self-report measure that assesses difficulties with emotion regulation across six domains. A total score is derived by summing all the items - ranging from 36 to 180. Higher scores indicate greater dysfunction in emotion regulation.
Measure: Change in Difficulties in Emotion Regulation Scale (DERS) score from post-treatment to 3-month follow-up assessment Time: 12 weeksDescription: Gold standard, clinician administered PTSD assessment tool; min. score=0, max=80, with higher scores representing greater PTSD symptoms
Measure: Change in Clinician Administered PTSD Scale (CAPS) score from baseline to post-treatment assessment Time: 9 weeksDescription: Gold standard, clinician administered PTSD assessment tool; min. score=0, max=80, with higher scores representing greater PTSD symptoms
Measure: Change in Clinician Administered PTSD Scale (CAPS) score from post-treatment to 3-month follow-up assessment Time: 12 weeks